Podcasts about vascular

Rachel Ludwig, Partner, DLA Piper, speaks with John Saran, Partner, Holland & Knight, Regan Parker, CEO, Association for Responsible Healthcare Investment, and Robbie Allen, CEO, U.S. Heart & Vascular, about the latest legal and regulatory developments related to corporate ownership of health care providers. They discuss the recent evolution of these laws and regulations at the state level, recurring trends, unintended consequences, and what the industry is doing to build trust and help shape the legal and regulatory landscape. From AHLA's Business Law and Governance Practice Group.Watch this episode: https://www.youtube.com/watch?v=Z9LWJzUczjkLearn more about AHLA's Business Law and Governance Practice Group: https://www.americanhealthlaw.org/practice-groups/practice-groups/business-law-and-governance Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/. 

This episode is brought to you by The Primal Skincare. Vascular surgeon Dr. Lily Johnston breaks down the definitive science of heart attack prevention and evaluates how modern diet and lifestyle choices directly accelerate or mitigate your cardiovascular risk. We explore the complex biological mechanisms underlying plaque formation and arterial rupture, moving beyond outdated dogmas to examine the real drivers of vascular disease: chronic inflammation, metabolic dysfunction, and the direct effects of insulin and glucose on your endothelial lining. Whether you are navigating the nuances of cholesterol management or looking for the most accurate diagnostic testing, this episode provides an authoritative, evidence-based roadmap to optimize your heart health and protect your arteries.In This Episode, We Reveal:The Pathophysiology of Plaque: How arterial plaque forms, why it ruptures, and the crucial clinical distinction between volatile soft plaque and stable calcified plaque.The Metabolic Drivers: The profound impact of chronic glucose and insulin elevation on arterial degradation.Advanced Diagnostics: Why standard lipid panels fail to show the whole picture, and how advanced imaging tools can detect early-stage disease.The Cholesterol Matrix: A scientific contextualization of LDL, the complexities of HDL, and whether elevated markers are a true risk factor on low-carbohydrate diets.Dietary Realities: A medical critique of common foods, the cardiovascular impact of processed ingredients, and the evidence supporting the Mediterranean diet.Scientific Resources & Dr. Johnston's Work:Dr. Lily Johnston (YouTube): https://www.youtube.com/@lilyjohnstonmdCleerly Health: https://cleerlyhealth.com/CardioRisk Ultrasound Testing: https://cardiorisk.com/HeartFlow CT Analysis: https://www.heartflow.com/

What if one of the most popular non-surgical procedures in aesthetic medicine is also one of the most misunderstood?In this episode of Plastic Surgery Uncensored, Dr. Rady Rahban takes an in-depth look at liquid rhinoplasty—a procedure that has surged in popularity thanks to its promise of immediate results, minimal downtime, and the ability to alter the appearance of the nose without surgery.But beneath the appeal lies a far more complex reality.Dr. Rahban breaks down what liquid rhinoplasty actually is, the anatomical principles that make it effective in certain situations, and why it is often being used to address concerns it was never designed to correct. He explains which patients may benefit from strategically placed filler, why others are poor candidates, and how an incomplete understanding of nasal anatomy can lead to devastating consequences.This conversation goes far beyond social media transformations and before-and-after photos. It explores the limitations of filler, the importance of proper patient selection, and the potentially catastrophic complications that can occur when injections are performed in one of the most anatomically complex regions of the face—including vascular occlusion, tissue necrosis, and even blindness.If you've ever considered a liquid rhinoplasty, been told filler can "fix" your nose, or want to understand the difference between temporary camouflage and true structural correction, this episode is essential listening.Topics covered include:• What liquid rhinoplasty actually is• How filler can improve select nasal contour irregularities• Who may be an appropriate candidate• Why some noses should never be treated with filler• The limitations of non-surgical nose reshaping• Vascular occlusion and tissue necrosis explained• The rare but devastating risk of blindness• Why nasal anatomy matters• Liquid rhinoplasty vs. surgical rhinoplasty• When surgery is the more appropriate solutionThis is a thoughtful, evidence-based discussion about one of aesthetic medicine's most controversial procedures—and the information every patient should understand before allowing anyone to inject their nose.✨ If you enjoyed this episode of Plastic Surgery Uncensored:✔️ Subscribe on Apple Podcasts, Spotify, or wherever you listen.✔️ Rate & Review—your feedback helps more people find us.✔️ Follow Dr. Rady Rahban across all platforms for daily insights, behind-the-scenes, and patient education:Instagram: @drradyrahbanTikTok: @radyrahbanMDYouTube: @Rady RahbanFacebook: @Rady Rahban✔️ Share this episode with someone considering plastic surgery—the right knowledge can save a life.

A 25-year-old pregnant woman presents with a 1-day history of progressive pain and swelling. The foot is cold, pulseless and neurologic function is deteriorating by the hour. Imaging shows a massive iliofemoral DVT. Now both the limb and the pregnancy are threatened. Do you anticoagulate, thrombolyse or operate? Join us as we break down the management and decision making behind this rare but devastating case.Hosts:·      Christian Hadeed -PGY 4 General Surgery, Brookdale Hospital Medical Center·      Paul Haser -Division Chief, Vascular Surgery, Brookdale Hospital Medical Center·      Andrew Harrington, Vascular surgery, Brookdale Hospital Medical Center·      Lucio Flores, Vascular surgery, Brookdale Hospital Medical CenterLearning objectives:-       Recognize the clinical presentation and pathophysiology of phlegmasia cerulea dolens-       Describe how pregnancy affects decision making in patients with phlegmasia and venous thromboembolic disease-       Discuss the goals of treatment for patients with DVT's and identify when operative intervention is indicated-       Describe the sequelae of DVT's and how this relates to post thrombotic syndrome-       Review the indications, risks, and limitations of anticoagulation, catheter-directed thrombolysis, thrombectomy, and fasciotomy in the management of DVT and phlegmasia.-       Explain the role of IVUS in managing venous thromboembolic disease and May Thurner syndromeReferences:-       Vedantham, S., Goldhaber, S. Z., Julian, J. A., Kahn, S. R., Jaff, M. R., Cohen, D. J., Magnuson, E., Razavi, M. K., Comerota, A. J., Gornik, H. L., Murphy, T. P., Lewis, L., Duncan, J. R., Nieters, P., Derfler, M. C., Filion, M., Gu, C.-S., Kee, S., Schneider, J., … Kearon, C. (2017). Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. New England Journal of Medicine, 377(23), 2240–2252. https://doi.org/10.1056/NEJMoa1615066-       Gomes, M. S., Guimarães, M., & Montenegro, N. (2019). Thrombolysis in pregnancy: A literature review. Journal of Maternal-Fetal & Neonatal Medicine, 32(14), 2418–2428. https://doi.org/10.1080/14767058.2018.1438402-       Mangla, A., & Hamad, H. (2023). May-Thurner syndrome. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554377/-       Bates, S. M., Rajasekhar, A., Middeldorp, S., McLintock, C., Rodger, M. A., James, A. H., et al. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy. Blood Advances, 2(22), 3317–3359. https://doi.org/10.1182/bloodadvances.2018024802-       Kahn, S. R., Comerota, A. J., Cushman, M., Evans, N. S., Ginsberg, J. S., Goldenberg, N. A., et al. (2014). The postthrombotic syndrome: Evidence-based prevention, diagnosis, and treatment strategies. Circulation, 130(18), 1636–1661. https://doi.org/10.1161/CIR.0000000000000130 https://pubmed.ncbi.nlm.nih.gov/25246013/Sponsor URL: https://www.goremedical.com/If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Could mushrooms hold the secret to better gut health, lower cholesterol, and can they protect your brain? Today, Professor Robin May, a leading microbiologist and the UK Government's Chief Scientific Officer, explores why our interest in mushrooms has exploded. He explains why they are not just another vegetable but could hold the key to better gut health, brain health, immune health, and lower cholesterol. By the end of the episode, you'll know which health claims about mushrooms are real, which are exaggerated and where the science is just too early to trust. You'll have a solid understanding of what mushrooms are really doing inside our bodies and how to unlock the secret health powers they hold. Should mushrooms become a regular part of your weekly shop rather than an occasional side dish? And if fungi have evolved alongside humans for millions of years, what else might they reveal about the future of nutrition and health?

Recorded live at the ESVS Vascular Graft and Endograft Infection Workshop in Groningen, this episode explores one of the most challenging complications in vascular surgery. We spoke with Prof. Ben Saleem, Prof. Xavier Berard, and workshop participants about diagnosis, treatment strategies, difficult clinical decisions, and the key lessons learned from this unique hands-on course. A practical discussion on managing vascular graft infections, featuring expert insights and real-world experience from across Europe.

6/2/2026 | Vascular

6/2/2026 | Vascular

6/2/2026 | Vascular

Welcome to the emDOCs.net podcast! Join us as we review our high-yield posts from our website emDOCs.net.Today on the emDOCs cast with Brit Long (@long_brit), we cover how to evaluate and manage acute limb ischemia. To continue to make this a worthwhile podcast for you to listen to, we appreciate any feedback and comments you may have for us. Please let us know!Subscribe to the podcast on one of the many platforms below:Apple iTunesSpotifyGoogle Play Send us Fan Mail

Send us Fan MailWe're joined by Jim's wife for this one.  We cover a bit of ground and have some laughs.Big WhackMoney back guaranteeIncenseRIP Wolves and WildVictoire'MN sports futilityDystopianFacial recognitionSchlitzYungblud concert reviewThe opposite of David Lee RothMark's Green Day connectionSongs of the Week:Vascular--PierreLove Removal Machine--The CultHappy Birthday Mark!#NewtsAppleValleyMNTheAscertainers@gmail.comPierre - "Vascular"The Cult - Love Removal Machine HD - YouTubeYUNGBLUD - Hello Heaven, Hello (Official Music Video) - YouTube (the good part starts at 2:50)Dillinger Four - Doublewhiskeycokenoice  (You be the judge--did Green Day rip them off?)

Medicine isn't what it used to be—not for the people practicing it. Independent physicians are becoming the exception, not the norm, as more doctors move into hospital systems, corporate groups, and academic networks. At the same time, the pipeline of specialists isn't keeping pace with growing patient needs, particularly in complex fields like vascular surgery, where workforce models show demand is set to outstrip supply in the years ahead. The result is a profession being pulled in two directions at once: toward consolidation on one hand, and rising clinical demand on the other.In that kind of environment, what does it really mean to make a major career move—and how do you weigh opportunity, stability, and personal priorities when the ground beneath the profession is shifting?That question sits at the heart of the latest episode of I Don't Care. Host Dr. Kevin Stevenson sits down with vascular surgeon Dr. Bradley Trinidad to unpack the realities behind a major geographic and professional transition. Their conversation explores how evolving medical technology, shifting employment models, and personal values intersect to shape modern physician careers.Key takeaways from the episode…Family can outweigh career momentum: Dr. Trinidad left a high-volume, successful practice to prioritize proximity to family and improve quality of life.Alignment is everything in hospital employment: Success depends on shared goals between physician and institution, especially in a system where most doctors are now employed.The future of vascular surgery is less invasive—and more complex: Advances in endovascular techniques are reducing the need for open surgery while increasing the need for specialized expertise.Dr. Bradley Trinidad is a board-certified vascular surgeon with expertise in both complex open and advanced endovascular procedures. He serves as Director of Vascular and Endovascular Surgery at Ascension Providence in Waco, Texas, where he leads program development and the delivery of high-acuity vascular care. He previously founded and led the vascular division at Northwest Texas Hospital and now contributes to surgical education as a Clinical Assistant Professor at Texas Tech University Health Sciences Center.

Discover how modern physicians are secretly swapping out old medical textbooks for Google and AI tools like Gemini to prep for your next surgery. On this episode of BackTable Industry, the hosts chat with Dr. Baxter about being eleven years out of training and how his learning focus has shifted from seeking the single “right” cutting-edge answer to optimizing patient care with available tools and resources. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 Introduction03:54 Finding Your Way as an Attending06:26 Internet Prep Habits12:28 Keeping Up in the Field21:13 IR Culture MacGyver26:44 Wrap Up Thanks --- More about this episode He describes realizing he had become a mid-career physician when younger partners began calling him for advice, despite his own imposter syndrome. They discuss how he prepares for infrequently performed or new procedures—using “phone a friend,” targeted Google searches, specific journals like Techniques in Vascular and Interventional Radiology, SIR's Digital Video Library, and AI tools such as Open Evidence —while being discerning about sources. Baxter explains overlap between specialties (e.g., double-J ureteral stents), variability between devices and when reps or formal training like cadaver labs are needed, and how IR's broad, evolving scope fosters a MacGyver-like, information-sharing culture. --- Resources Open Evidencehttps://www.openevidence.com/ Techniques in Vascular nad Interventional Radiologyhttps://www.sciencedirect.com/journal/techniques-in-vascular-and-interventional-radiology Digital Video Library of the Society of Interventional Radiology (SIR)https://www.youtube.com/c/SocietyofInterventionalRadiology --- Backtable Industry is the go-to podcast for healthcare leaders, business-minded providers, and innovators that are shaping the future of healthcare. Download the free BackTable app to get early access to new episodes.► https://www.backtable.com/app

En este episodio de En Consulta, revelamos el peligro oculto detrás de las piernas cansadas y la insuficiencia venosa. Los doctores Miguel Ángel Sánchez Pérez y Jaime Alberto Valdés Flores, especialistas en Angiología, Cirugía Vascular y Endovascular, te dicen qué hacer en una emergencia, cómo influye el estrés en tus venas y todas las soluciones disponibles. ¡Tu salud vascular no puede esperar! Dale 'Play' y toma el control de tu bienestar hoy mismo.

It's PodQuiz Monday! Test your knowledge from a recent episode with a quick set of audio flashcards designed to reinforce what you learned. These mini-reviews are a great way to study on the go, and they give you a taste of what it's like inside Study Sesh, my audio study tool for busy nursing students. If you need a brush-up on vascular assessments before you do this podquiz, I've got you covered in episode ENCORE! #274: Introduction to Vascular Assessment.

Every other week I republish one of my most popular or impactful episodes from my backlog of over 450 episodes. This week I'm highlighting Episode 274, which walks you through how to perform a vascular assessment. ___________________ ⁠Full Transcript⁠- Read the article "Performing a Vascular Assessment" and view references ⁠Nursing School Survival Blueprint⁠ - Nursing school gets easier when you have a system. This free Blueprint walks you through the key shifts that separate struggling students from thriving ones — download it and start applying them this week.

Dr. Clint Sliker breaks down the critical imaging findings of cardiac and non-thoracic vascular trauma, highlighting how these rare but life-threatening injuries appear on CT. He shares practical insights to help radiologists recognize subtle signs, choose the right protocols, and maintain a high index of suspicion in high-stakes trauma cases. Imaging of Cardiac and NonaorticThoracic Vascular Trauma. Costenbader and Beheshtian et al. RadioGraphics 2026; 46(2):e250097. 

5/12/2026 | Vascular

Your arteries may be older than you are--here's how we find out. Credit available for this activity expires: 5/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/episode-3-carotid-ultrasound-seeing-vascular-age-2026a1000een?ecd=bdc_podcast_libsyn_mscpedu

Vascular trauma care looks a lot different when the OR is improvised, supplies are limited, and limb salvage decisions cannot wait. On this episode of the BackTable Podcast, host Dr. Sabeen Dhand interviews vascular surgeon Dr. Ahmad Hussain, a Southern California private-practice “hired gun” who volunteered on a WHO/UN-coordinated humanitarian mission to Gaza after an orthopedic colleague requested vascular surgeons due to widespread limb loss. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction04:02 - Why Volunteer In Gaza?07:41 - Logistics and Crossing Into Gaza10:45 - Hospital as Refugee Camp13:34 - First Vascular Trauma Case18:24 - Mass Casualty Triage23:20 - Kids Guiding Doctors27:09 - Evacuation Uncertainty32:03 - Would You Go Back?37:55 - How to Volunteer39:30 - Show Wrap Up and Credits --- More about this episode Dr. Hussain describes entering through the Rafah border with suitcases of medical supplies, working in a hospital functioning as a refugee camp for tens of thousands, and treating shrapnel-related vascular trauma with limited imaging (mainly ultrasound and X-ray), scarce anesthesia, and minimal surgical resources, relying heavily on skilled local medical students and residents. He recounts mass-casualty triage, the emotional impact of caring for injured children, bonding with the children who assisted the volunteers, and the dangerous, militarized evacuation via Israel with U.S. embassy assistance. He says he wants to return, but notes tightened restrictions and dwindling aid, and he recommends other organizations, noting any specialty of medical professionals should consider volunteering. --- Resources Gift of Disability Alleviation (GODA)https://indushospital.ca/appeal/gift-of-disability-alleviation-goda/ --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

CardioNerds (Drs. Natalie Marrero, Shivani Reddy, and Rebecca S. Steinberg), discuss the role of SGLT2i in cancer therapy-related cardiac dysfunction (CTRCD) with Dr. Manu Murali Mysore. This episode was produced as part of the CardioNerds Academy curriculum by House Taussig under the guidance of House Chief, Dr. Natalie Marrero, and Academy Program Director, Dr. Gurleen Kaur. A matching review article will be published in US Cardiology Review, the official journal of CardioNerds. Audio editing for this episode was performed by CardioNerds Intern, Dr. Julia Marques Fernandes. Summary: Cancer therapy-related cardiac dysfunction (CTRCD) spans a spectrum from subclinical biomarker elevation to overt heart failure, with risk amplified by preexisting cardiovascular disease, diabetes, hypertension, obesity, and exposure to therapies, such as anthracyclines, HER2-targeted therapies, or radiation. This episode explores the emerging and promising role of SGLT2 inhibitors as a cardioprotective adjunct in cardio-oncology — examining mechanisms, clinical evidence, ongoing trials, and critical knowledge gaps — while affirming that guideline-directed medical therapy remains the cornerstone of prevention and treatment. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Cardio-Oncology PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls CTRCD is a spectrum — catch it early. CTRCD ranges from subclinical injury detected by imaging and biomarkers to overt heart failure. Early identification in high-risk patients (preexisting CVD, diabetes, HTN, obesity, anthracycline/HER2/radiation exposure) is essential, and early initiation of guideline-directed medical therapy — including ACE inhibitors/ARBs/ARNIs, mineralocorticoid receptor antagonists, and beta-blockers — remains the backbone of prevention and treatment to preserve LVEF and allow safe continuation of cancer therapy. SGLT2 inhibitors are a promising new pillar of cardioprotection in cardio-oncology. They act through a unique combination of mechanisms: renal effects, metabolic reprogramming of the myocardium, anti-inflammatory and antioxidant pathways, and vascular fibrosis modulation — making them a compelling complement to standard therapies rather than a replacement. Early clinical data is encouraging but not yet definitive. The 2024 EMPACARD-PILOT trial demonstrated preserved LVEF and reduced CTRCD in higher-risk patients with diabetes or kidney disease. Ongoing trials — EMPACT and PROTECT — are actively exploring SGLT2 inhibitors for primary prevention during anthracycline and HER2-targeted therapy. SGLT2 inhibitors are NOT yet indicated for ICI-related myocarditis. Immune checkpoint inhibitor (ICI)-related myocarditis is mechanistically immune-driven. While SGLT2 inhibitors have theoretically anti-inflammatory benefits, there is currently no clinical evidence to support their use in this specific setting. The use of SGLT2 inhibitors should be guided by patient risk, existing indications, and ongoing research. Large prospective trials, clarity on timing and patient selection, long-term safety data, and deeper mechanistic understanding in humans remain the most urgent gaps in the field before broader adoption can be recommended. References Theofilis P, Vlachakis PK, Oikonomou E, et al. Cancer therapy-related cardiac dysfunction: A review of current trends in epidemiology, diagnosis, and treatment. Biomedicines. 2024;12(12):2914. doi:10.3390/biomedicines12122914. https://pubmed.ncbi.nlm.nih.gov/39767820/ Lyon AR, Dent S, Stanway S, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail. 2020;22(11):1945-1960. doi:10.1002/ejhf.1920. https://pmc.ncbi.nlm.nih.gov/articles/PMC8019326/ Li X, Li Y, Zhang T, et al. Role of cardioprotective agents on chemotherapy-induced heart failure: A systematic review and network meta-analysis of randomized controlled trials. Pharmacol Res. 2020;151(104577):104577. doi:10.1016/j.phrs.2019.104577. https://pubmed.ncbi.nlm.nih.gov/31790821/ Lee YH, Lim S, Davies MJ. Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitors. Nat Rev Endocrinol. 2025;21(12):783-798. doi:10.1038/s41574-025-01170-4. https://pubmed.ncbi.nlm.nih.gov/40935880/ Dabour MS, George MY, Daniel MR, Blaes AH, Zordoky BN. The cardioprotective and anticancer effects of SGLT2 inhibitors: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 2024;6(2):159-182. doi:10.1016/j.jaccao.2024.01.007. https://pubmed.ncbi.nlm.nih.gov/38774006/ Armillotta M, Angeli F, Paolisso P, et al. Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure. Pharmacol Ther. 2025;270(108861):108861. doi:10.1016/j.pharmthera.2025.10886. https://pubmed.ncbi.nlm.nih.gov/40245989/ Góes-Santos BR, Castro PC, Girardi ACC, Antunes-Correa LM, Davel AP. Vascular effects of SGLT2 inhibitors: evidence and mechanisms. Am J Physiol Cell Physiol. 2025;329(4):C1150-C1160. doi:10.1152/ajpcell.00569.2025. https://pubmed.ncbi.nlm.nih.gov/40908107/ Daniele AJ, Gregorietti V, Costa D, López-Fernández T. Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trial. CardioOncology. 2024;10(1):58. doi:10.1186/s40959-024-00260-y. https://pubmed.ncbi.nlm.nih.gov/39237985/ Clinicaltrials.gov. Clinicaltrials.gov. Accessed April 16, 2026. https://clinicaltrials.gov/study/NCT05271162 Greco A, Quagliariello V, Rizzo G, et al. SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial. CardioOncology. 2025;11(1):79. doi:10.1186/s40959-025-00368-9. https://pmc.ncbi.nlm.nih.gov/articles/PMC12400668/ Key Guideline Reference: Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS). Eur Heart J Cardiovasc Imaging. 2022;23(10):e333-e465. doi:10.1093/ehjci/jeac106. https://pubmed.ncbi.nlm.nih.gov/36017575/ Be sure to check out the corresponding review article on the cardioprotective role of SGLT2 inhibitors in CTRCD that will be published in US Cardiology Review, the official journal of CardioNerds. Additionally, please reference CardioNerds Cardio-Oncology Episodes 261 and 274 for related content.

Mehlman Qbanks: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://qbanks.mehlmanmedical.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/mehlman_medical/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Telegram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://mehlmanmedical.com/subscribe/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Estudo comprova que medicamento utilizado para controle da obesidade também reduz o risco de problemas cardiovasculares, mantendo as mesmas contraindicações

As interventional radiology cements its position as a primary clinical responder for acute arterial hemorrhage, what if you could achieve rapid and durable arterial occlusion with a single, highly deliverable device? In this episode of the BackTable Podcast, Dr. Alex Villalobos (UNC), Dr. Nima Kokabi (UNC), and Dr. Brian Funaki (UChicago) join host Dr. Kavi Krishnasamy to explore the shifting paradigms of arterial embolization in a case-based discussion highlighting modern vascular plug technologies.--- Get the BackTable app https://www.backtable.com/app --- This podcast is supported by Okami Medicalhttps://okamimedical.com/ --- Timestamps 00:00 - Introduction01:24 - Trauma Activation Workflow06:42 - Empiric Arterial Embolization Indications10:40 - Embolic Agent Preferences and Value Analysis17:18 - Embolics on the Shelf19:32 - LOBO Plug Use Cases20:58 - Case 1: Abdominal Wall Hematoma23:54 - LOBO Advantages, Cost, and Microcatheter Compatibility26:33 - Alternative Access Approaches30:31 - LOBO Sizing and Trackability35:26 - Pusher Wire Features38:20 - Delivery Catheter Requirements43:41 - Case 2: Retroperitoneal Bleed45:15 - LOBO Deployment Technique49:41 - Case 3: Splenic Trauma53:51 - Occlusion Time and Adjunct Embolics57:07 - Closing Remarks --- More about this episode The panel begins by discussing the range of embolic options and combinations at their disposal, sharing their preferences and treatment algorithms in various clinical scenarios. In particular, they emphasize the need for tools that provide immediate, predictable occlusion without the technical burden and cost of needing to deploy multiple embolic agents. The physicians go on to focus on Okami Medical's LOBO vascular plug as a primary solution for rapid vessel occlusion, highlighting the micro-pore architecture and unique deliverability through microcatheters that make it advantageous for precise positioning and reliable embolization. Exploring its use in cases including rectus sheath hematomas, retroperitoneal bleeding, and splenic trauma, the physicians detail the technical nuances of sizing and positioning the LOBO as well as the long-term advantages of its artifact-free design. This episode ultimately underscores a growing preference for streamlined arterial embolization workflows that prioritize rapid stasis and clinical predictability while leveraging the strengths of a multimodal embolic toolkit.

4/3/2026 | Vascular

Jacob Soucy (@JacobWSoucy) hosts an inside look at a timely and thought-provoking editorial published in The Vascular Specialist, the official news magazine of the Society for Vascular Surgery.   In this episode, we explore the evolving conversation around surgical call and compensation through the lens of the editorial "A Call for Call Pay." The discussion challenges the traditional framing of call as simply part of the job and instead examines it as a measurable burden of availability that carries legal, financial, and personal implications. This conversation highlights why the valuation of call may represent one of the defining structural issues in modern vascular surgery practice.   Jacob speaks with Dr. Malachi G. Sheahan III about the motivation behind the piece, how hospital systems value call, what the true cost of call coverage is, and what the future may hold if the current model remains unchanged.   Show Guest Dr. Malachi G. Sheahan III is Professor and Chair of Surgery at Louisiana State University Health Sciences Center and Chief of the Division of Vascular Surgery. He previously served as Program Director for both the fellowship and integrated residency in vascular surgery at LSU. Nationally, Dr. Sheahan serves as Secretary of the Society for Vascular Surgery and as Chief Medical Editor of The Vascular Specialist. With more than two decades in academic surgery, he is a recognized leader in vascular education, workforce policy, and advocacy within the specialty.   Resources and Social Media X (Twitter): @lsuvascular   Read the editorial: "A Call for Call Pay" – The Vascular Specialist   Special thanks to Dr. Malachi G. Sheahan III for sharing his time and insight and for his ongoing contributions to vascular surgery.   Follow us @audiblebleeding for updates on upcoming episodes and new research features. Learn more about us at audiblebleeding/about and share your feedback through our listener survey.   *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

Life Behind the Numbers of Amputees and Limb Difference     April is Limb Loss and Limb Difference Awareness Month, and this year on the podcast, I'm doing something that means so much to me. Instead of focusing only on my own story, I'm opening the door for other amputees to share theirs. That has become a tradition for me over the last five seasons, and this year I'm building the entire month around one powerful theme: Survivors to Warriors. I truly cannot wait for you to hear these interviews, because the young adults I have coming on embody courage, resilience, grit, and hope in a way that will leave you inspired. Their stories are raw, real, and deeply moving, and I'm honored to call each of them my friend. As I prepared for this month, I wanted to begin with something eye-opening: the statistics. Because the truth is, before I became an amputee seven years ago, I hardly ever noticed amputees around me. Maybe once in a while I'd see someone, but it felt rare. Now, just like when you buy a certain car and suddenly see it everywhere, I notice amputees much more often. Even so, the numbers tell me I should be seeing even more. And that is what really stopped me in my tracks. Worldwide, someone loses a limb every thirty seconds. There are tens of millions of people around the world living with limb loss, and what absolutely breaks my heart is that up to ninety percent of them do not have access to prosthetic care. Ninety percent. That number is staggering. And it hits close to home for me because I know what it feels like to have the hope of mobility threatened. Amputee Coalition Statistics used on American Endovascular & Amputation Prevention site, April 25, 2022   Before my elective amputation, I was told everything would be covered. I did my homework because I knew prosthetics were expensive, and I needed the reassurance that if I moved forward with surgery, I would have access to the leg I needed. Then, about a month after surgery, we filed the insurance paperwork and I was denied. I can tell you without hesitation that those four weeks were some of the hardest weeks of my life. In the grand scheme of seven years, it may look like a blink. But in the moment, it felt like everything. I had dreams, goals, and visions of what life could be after amputation, and suddenly an insurance company was telling me no. So I fought. Every single weekday, I called. I kept climbing the ladder, talking to the next person and then the next. I refused to sit back and wait for someone else to decide my future. That season demanded every ounce of emotional and mental strength I had. I had to advocate for myself when I was exhausted, scared, and uncertain. And when I think about the reality that so many people around the world never get that access at all, it is heartbreaking.   Amputee Coalition Statistics used on American Endovascular & Amputation Prevention site, April 25, 2022   The leading causes of limb loss are also telling. Vascular disease, including diabetes, makes up the largest percentage. Trauma is close behind, including accidents and injuries. Then comes cancer, though at a much smaller percentage. My own amputation came after years of surgeries following a karate injury, and eventually I made the deeply personal decision to amputate. Elective amputation is not an easy road, and whether amputation happens in an instant or after years of medical struggle, both journeys carry their own kind of trauma. That's the part people do not always see. Yes, limb loss is physical. It is visible. But the emotional and mental toll can be just as life-altering. Depression, anxiety, PTSD, fear, isolation, and loss of confidence are very real parts of this journey for so many amputees. People may see someone walking on a prosthesis and assume they are doing fine, but they do not always see the inner battle. They do not see the fear of falling, the anxiety of being watched, the struggle to trust your body again, or the grief of trying to figure out who you are now.   Amputee Coalition Statistics used on American Endovascular & Amputation Prevention site, April 25, 2022   Physiopedia: The 5 Stages of Grief and Loss; Axelrod, J. September 26, 2018, https://psychcentral.com/lib/the-5-stages-of-loss-and-grief/   Prime Care, Blog by Eddie Zepeda. Published, January 20, 2025   And then there is phantom pain, something many amputees know all too well. Phantom pain and sensations can range from mild to absolutely overwhelming. It can feel like burning, stabbing, cramping, stinging, or relentless discomfort that comes out of nowhere and hits like a truck. It is one more reminder that the amputee journey is layered, complicated, and often invisible to the outside world. That is exactly why this month matters so much to me. I want these interviews to shine a light on the real lives behind the statistics. I want you to hear from young adults who have endured the unimaginable and are now learning how to rise, rebuild, and become warriors. Their stories deserve to be heard, and I know they will inspire anyone who listens. So as we step into Limb Loss and Limb Difference Awareness Month, I hope you'll join me. Like, share, subscribe, and most of all, listen. These stories matter. These lives matter. And together, we can bring more awareness, more compassion, and more hope to a community that deserves to be seen. And as always, Be healthy, Be happy, Be YOU!!!   Much love,

Ask most private practice owners how many hours they work per week, and you'll typically hear way more than 40. Is it possible to run a successful practice in less than that? My guest today is doing it, and he describes how in this episode. Dr. Shah is an interventional cardiologist with Prime Heart and Vascular in Dallas Area. He is also the founder of GoLean Health, a staffing company for healthcare practices. He is passionate about patient care and helping other physicians thrive in private practice. In this episode Carl White and Dr. Rishin Shah discuss: His practice's description in detail for context, and what a typical day looks like for him Diverse revenue streams and operational efficiencies are the key ingredients How Dr. Shah reached this state and what's next This Episode is Sponsored By Next Step Advisory This episode is sponsored by Next Step Advisory. Running a medical practice today means managing patient care, reimbursement pressure, staffing shortages, and ever-changing compliance requirements. Managing your people cannot just be administrative. It must support the business. Next Step Advisory provides senior level, fractional HR leadership to medical practices and healthcare adjacent businesses nationwide. With more than 30 years of HR experience, including deep work in healthcare and professional services environments, Next Step helps practice owners strengthen their teams, reduce risk, improve retention, and build the people infrastructure needed to scale. If your practice is growing or feeling operational strain, experienced HR leadership may be the advantage you are missing.  Learn more at nextstepadvisory.us. Want to be a guest on PracticeCare®? Have an experience with a business issue you think others will benefit from? Come on PracticeCare® and tell the world! Here's the link where you can get the process started. Connect with Dr. Rishin Shah https://www.linkedin.com/in/rishin-shah/ Connect with Carl White Website: http://www.marketvisorygroup.com Email:  whitec@marketvisorygroup.com Facebook:  https://www.facebook.com/marketvisorygroup YouTube: https://www.youtube.com/channel/UCD9BLCu_i2ezBj1ktUHVmig LinkedIn: http://www.linkedin.com/in/healthcaremktg

In this episode, Duane Mancini speaks with vascular neurologist Anit Behera about what it takes to improve stroke care from the ER through long-term recovery. Anit shares his path through an MD-PhD in outcomes research, how consulting and clinical trials shaped his innovation mindset, and why stroke care advancement spans four phases: prevention, acute treatment, post-acute care, and rehabilitation. He explains where he sees major opportunity next, pointing to emerging devices and research in post-stroke rehab alongside stronger prevention strategies and better health literacy. The conversation also breaks down how clinicians evaluate new technologies, emphasizing rigorous data, patient safety, and real-world workflow fit, plus the role of key opinion leaders and conferences in driving adoption. Anit Behera LinkedInDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedInThank you to our sponsors: Ward Law and JumpStart Inc.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/QKV865. CME/AAPA credit will be available until April 3, 2027.Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/QKV865. CME/AAPA credit will be available until April 3, 2027.Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/QKV865. CME/AAPA credit will be available until April 3, 2027.Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/QKV865. CME/AAPA credit will be available until April 3, 2027.Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/QKV865. CME/AAPA credit will be available until April 3, 2027.Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

Contributor: Travis Barlock, MD Educational Pearls: What is an internal jugular catheter (IJ) and when do we use it? IJs are catheters that can be placed in either the left or the right internal jugular vein to provide central venous catheter (CVC) access. CVCs can be placed in other locations other than the internal jugular vein (i.e. subclavian vein or femoral veins). IJs are used when the patient may require long-term venous access or have to receive hyperosmolar solutions (such as solutions with high glucose content for parenteral nutrition); solutions with extreme pHs (9); or vesicant drugs (drugs that can cause tissue necrosis with extravasation). They are not to be confused with EJs (external jugular vein catheters) which can be placed in difficult to peripherally catheterize patients. EJs function similarly to a peripheral IV. The advantage of IJs is their location in larger veins brings them closer to direct access to the heart (i.e. the right internal jugular vein will provide immediate/quicker access to the right atrium to the heart.) What are concerns of using a right internal jugular catheter versus one in the left? The right internal jugular vein provides quick access to the heart via the right atrium, making it ideal in critically ill patients who may require vasopressor support. However it is also the site commonly used for additional cannulation procedures such as hemodialysis, pulmonary artery pressure measurements, extracorporeal membrane oxygenation (ECMO) and transvenous pacemaker placement. These procedures are not uncommon in critically ill patients who also required a CVC for initial hemodynamic support via vasopressors. Gharaibeh et al. found that patients who received a right IJ and hemodialysis had a higher need for re-insertion of the hemodialysis catheter (40% compared to 2.6% in the left IJ group). Furthermore, it was found that with a right IJ, hemodialysis catheters had to be exchanged by a guidewire in 23% of those with a right IJ as opposed to 0.9% in the left IJ group (a guidewire exchange is often considered a salvage technique to try and maintain access). Big Takeaway? If you are able to obtain an IJ on the right, you can likely obtain one on the left, and if considering longitudinal care for your patient, consider obtaining an IJ on the left to allow for future critical access in the right IJ. References Gharaibeh KA, Abdelhafez MO, Guedze KEB, Siddiqi H, Hamadah AM, Verceles AC. Impact of initial jugular vein insertion site selection for central venous catheter placement on hemodialysis catheter complications. Journal of Critical Care. 2025;87:155011. doi:10.1016/j.jcrc.2024.155011 Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA: A Cancer Journal for Clinicians. 2008;58(6):323-346. doi:10.3322/CA.2008.0015 Summarized by Dan Orbidan, OMS2 | Edited by Dan Orbidan & Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/ Join our mailing list: http://eepurl.com/c9ouHf

With the single-stick technique proving to be an effective addition to the venous line placement toolkit, what is stopping IRs from venturing beyond the traditional dual-incision approach? In this episode of the BackTable Podcast, pediatric interventional radiologist Dr. Kevin Wong of USA Health joins host Dr. Ally Baheti to review the single-stick technique for central venous access, a method widely utilized in pediatric practice. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction01:35 - Origins of Single-Stick Access03:10 - Setup and Bending the Needle07:17 - Tunneling to the IJ10:06 - Line Positioning and Measurement14:45 - Wire Handling Considerations18:55 - Clinical Advantages of Single-Stick Access21:27 - Femoral Single-Stick Tips23:41 - Common Mistakes and Pitfalls27:39 - Needle-Free Lidocaine Administration30:48 - Closing Remarks --- More about this episode Delving into the origins, technical nuances, and clinical advantages, the physicians explore how the single-stick technique can reduce the risk of infection and minimize interference with other lines and tubing to improve patient care. The discussion provides a detailed technical breakdown of the procedure, offering a masterclass on navigating the curves up the neck as well as the equipment selection and sizing necessary to facilitate the process. With the aid of visual slides and demonstrations, Dr. Wong steps us through the specifics of bending the access needle, maneuvering tools to adapt to anatomical configurations, and handling ultrasound movement to confirm and maintain a safe trajectory throughout the procedure. The conversation emphasizes the tactile “feel” and attention to forces acting on the wire that are required to appropriately position the catheter.Recognizing the logistical constraints that make it challenging for attendings to regularly adopt alternative procedural techniques, this episode serves as an accessible primer for clinicians looking to broaden their options for venous access with this effective, patient-centric technique.

Host: Darryl S. Chutka, M.D.  Guest: Kathryn del Valle, M.D.  Chronic liver disease can result in a variety of complications which can involve multiple organs. One of these complications can occur in the pulmonary vascular system. Two of the most clinically significant include hepatopulmonary syndrome and Portopulmonary hypertension. Patients with these syndromes may present to their primary care provider and if the medical condition is unrecognized, it can affect morbidity and ultimately the prognosis of the patient. What are the early symptoms and physical findings of hepatopulmonary syndrome and Portopulmonary hypertension? How are they diagnosed, and should we be screening patients with chronic liver disease for these pulmonary vascular disorders? My guest for this podcast is Dr. Kathryn del Valle, from the Division of Pulmonary and Critical Care at the Mayo Clinic and we'll be discussing “Pulmonary Vascular Complications of Liver Disease”.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

В новия епизод на Ratio Weekly Петко и Никола Кереков се гмуркат в науката за деменциите – от най-разпространената форма, болестта на Алцхаймер, до по-рядко обсъждани състояния като съдовата деменция, деменцията с телца на Леви и фронтотемпоралната деменция. Говорят за това какво всъщност се случва в мозъка – от натрупването на неправилно нагънати протеини и загубата на невронни връзки до последиците от инсулти и нарушено кръвоснабдяване. В епизода става дума и за генетичните фактори, включително ролята на гена APOE при риска от Алцхаймер, както и за това защо различните видове деменция често се бъркат една с друга. Разглеждат се и характерните симптоми – от проблеми с паметта и ориентацията до промени в поведението, езика и личността – които показват колко различно може да изглежда когнитивният спад. Представяне на гостите: Д-р Дияна Бележанска е специалист по неврология в Клиниката по неврология към УМБАЛ “Александровска”. Асистент е в Медицинския университет в София. Придобива научна степен “доктор” след защита на дисертационен труд на тема: “Невропсихологични, невроизобразяващи и ликворни биомаркери за болест на Алцхаймер и сродни заболявания”. Основните ѝ интереси са в областта на невродегенеративните заболявания, протичащи с паметови нарушения. Бойко Неов е молекулярен биолог и д-р по паразитология с разнообразни интереси във всички сфери на науката. Към момента той доцент по генетика към Институт по биоразнообразие и Екосистемни изследвания на БАН. Споменато в епизода: https://en.wikipedia.org/wiki/Alzheimer%27s_disease https://en.wikipedia.org/wiki/Vascular_dementia https://en.wikipedia.org/wiki/Lewy_body_dementia https://en.wikipedia.org/wiki/Frontotemporal_dementia https://en.wikipedia.org/wiki/Apolipoprotein_E За подкаста: В епизодите на Ratio Weekly, нашата импровизирана научна новинарска емисия, молекулярният биолог Никола Кереков в компанията на харизматичния водещ Петко Желязов ви представят най-новите открития и най-любопитните постижения в сферата на науката, технологиите и медицината от изминалата седмица. В тази мини-серия на Ratio Podcast говорим за неща като това как да общуваме ефективно с котките, защо китовете се самоубиват и какво живее на Венера.

[#49] Vascular Occlusion (VO) is the scariest phrase in medical aesthetics. In today's episode of Fill Me In, Jon and Nicole go behind the scenes of a viral filler complication with Kristin Dobry (@ConfidenceByKristin).Kristin breaks down exactly how she managed a vascular occlusion in a patient's temple. We discuss what caused the VO, the importance of an emergency kit, and the step-by-step protocol used to ensure a full recovery with zero scarring. Whether you are a seasoned injector or a patient curious about dermal filler safety, this episode covers:Filler Safety: The debate between 22g vs. 25g cannulas.VO Symptoms: How to spot a reticular rash and delayed capillary refill.Anatomy Expertise: Why even the best injectors face complications.Patient Communication: The RIGHT way to discuss filler risks during consents.Follow Kristin on Instagram: https://www.instagram.com/confidencebykristin/?hl=enBook with Kristin:https://www.theconfidencebar.com/**DISCLAIMER** The content of this episode of Fill Me In: An Aesthetics Podcast is intended for educational and informational purposes only and does not constitute medical advice. The hosts, guests, and producers of this podcast do not endorse or recommend the use of any medical product, procedure, or treatment without proper clinical training, patient assessment, and full informed consent. Listeners are strongly advised to consult with their healthcare providers and adhere to all applicable laws and regulatory guidelines. We expressly disclaim any and all liability for any outcomes related to the use or misuse of the information presented in this episode.Fill Me In is hosted by Jonathan LeSuer, MSN, NP-C and Nicole Bauer, MSN, APRN, FNP-BC. Follow Fill Me In on Instagram!https://www.instagram.com/thefillmeinpod/Follow Nicole on Instagram:https://www.instagram.com/aestheticnursenicole/Nicole's Patreon:https://www.patreon.com/aestheticnursenicole?utm_source=searchExhibit Medical Aesthetics website:https://exhibitmedicalaesthetics.com/Follow Jon on Instagram:https://www.instagram.com/injectorjon/Jon's Patreon:https://www.patreon.com/Injectorjon?utm_source=searchTox and Pout Aesthetics website:https://toxandpout.com/Join Moxie! Is the business side of your Med Spa overwhelming? Moxie is the all-in-one growth system built to help you scale without the stress. Get software, marketing, compliance tools, and expert coaching all in one place. Fill Me In listeners get $500 off their launch fee! ➡️ Visit www.joinmoxie.com/fillmein Producer of Fill Me In: Joey Ginexi

Drs. Kat Talcott and Priya Vakharia join to discuss the March 2026 edition of Retinal Physician, including bicistronic gene therapy, photobiomodulation, uveitis fellowships, and polypoidal vascular choroidopathy. Listeners, as we approach our 500th episode, we will be having a Q&A session featuring questions and thoughts from you! It's your chance to have your voice heard on the podcast.Please record an audio / video of your question and upload it to the linked form (https://forms.gle/nyv3fvCHZJ4XzQe67). We are excited to hear what you have to say!

Shot Targets Clogged Arteries Blocked arteries are not the main cause of heart attacks. Unstable plaque driven by oxidation, inflammation, and high insulin is. In this episode, Ben explains the 5 key drivers of arterial damage: Oxidized LDL Endothelial inflammation Low nitric oxide High triglycerides Chronically elevated insulin He shares a simple 60-second vascular support shot designed to: Support nitric oxide Lower insulin spikes Reduce inflammation Protect LDL from oxidation Key ingredients include beetroot or lemon, apple cider vinegar, ginger or turmeric, and high polyphenol fresh pressed olive oil. Small daily habits shape long-term heart health. Precision over panic.

MCAS. POTS. Hypermobility. GI symptoms that don't quite fit the usual boxes.   On this episode of The Gut Show, Dr. Alexis Cutchins joins us to unpack what cardiology has to do with GI—and why these systems are far more connected than most people realize.   We dive into the emerging overlap between cardiology, gastroenterology, and immune-driven conditions, exploring why these patterns so often show up together, what red flags clinicians should be watching for, and why GI symptoms may actually start far beyond the gut—especially when dysautonomia, heart palpitations, dizziness, and persistent fatigue are part of the picture.   Mentioned in this episode:  MASTER Method Membership FREE IBS Warrior Summit Take the quiz: What's your poop personality? MCAS episode   About our guest:  Dr. Alexis Cutchins is a board-certified Cardiologist and founder of Cutchins Cardiovascular Medicine. I began this work after years of caring for patients with POTS, MCAS, hypermobility, and other conditions that many doctors were not prepared to manage. My dedication to this patient community is what led me to build a practice centered on their needs. I wanted to create something different for people who are often under-recognized and left without answers. At Cutchins Cardiovascular Medicine, we provide inclusive, high quality support for those living with complex chronic illness. Follow on Instagram   Thank you to our partners:   @imodifyhealth is the leader in evidence-based, medically-tailored meal delivery offering Monash Certified low FODMAP, Gluten free, and Mediterranean meals - expertly crafted to help you achieve better symptom control AND improve overall health.    The best part? They make it easy by doing all prep work for you. Simply choose the meals you want, stock your fridge or freezer when meals arrive at your door, then heat and enjoy when you're ready. Delicious meals. Less stress. Complete peace of mind.   Check out modifyhealth.com and save 35% off your first order plus free shipping across the US with code: THEGUTSHOW.     @fodzyme is the world's first enzyme supplement specialized to target FODMAPs.   When sprinkled on or mixed with high-FODMAP meals, FODZYME's novel patent-pending enzyme blend breaks down fructan, GOS and lactose before they can trigger bloating, gas and other digestive issues.    With FODZYME, enjoy garlic, onion, wheat, brussels sprouts, beans, dairy and more — worry free! Discover the power of FODZYME's digestive enzyme blend and eat the foods you love and miss.   Visit fodzyme.com and save 20% off your first order with code THEGUTSHOW. One use per customer.   @mbiotaelemental is the next generation of the elemental diet. Developed with leading gastroenterologists and food scientists, it's the first formula that's both clinically effective AND genuinely easy to drink.   If you're looking for an option to support SIBO or your gut, mBIOTA Elemental may be one to consider. Learn more at mbiota.com and save 20% on their two-week protocol with code GUTIVATE.    

Peripheral Artery Disease is more prevalent than most cancers — and often deadlier when missed. Yet it is still underdiagnosed, misunderstood, and too often treated in silos. On this episode of The Heart of Innovation, hosts Kym McNicholas and Dr. John Phillips, Interventional Cardiologist, sit down with Dr. David Dexter, Vascular Surgeon at Sentara Health, who was named the Global PAD Association's Multidisciplinary Team Leader of the Year through the Global PAD Impact Awards. This PAD Awareness Day — observed the third Saturday of every February during American Heart Month — we are talking about why leg health is heart health. PAD is not just a leg problem. Blocked leg arteries are a warning sign for heart attack and stroke. And patients deserve a coordinated vascular care team — not fragmented care. In this conversation, we break down: • Why PAD is more common than many cancers — yet still diagnosed too late • The danger of treating patients in silos • What a true multidisciplinary vascular care team looks like • How cardiology, vascular surgery, podiatry, wound care, and primary care must work together • Why "Sock It to PAD" and Red Sock Day matter during American Heart Month • What patients should demand from their care teams Too many amputations are preventable. Too many heart attacks have warning signs in the legs first. It is time to connect the dots. If you or someone you love has leg pain when walking, numbness, wounds that won't heal, diabetes, kidney disease, or a history of smoking — this conversation could save a limb and a life.

Vascular surgeon Paula Muto discusses her article "Give the health care dollar back to patients." Paula argues that the government shutdown over health care funding misses the real issue of administrative bloat consuming 75 percent of spending. She explains how corporate consolidation and third-party administrators have turned patient coverage into captivity while driving independent physicians out of business. The conversation highlights the need to bypass insurance middlemen by subsidizing patients directly through Health Savings Accounts and vouchers. Paula advocates for transparent pricing and ending network restrictions to restore the sacred relationship between healers and those they serve. Discover how giving Americans control over their own health care dollars can build equity and lower costs for everyone. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

In this episode, we are joined by pediatric dermatologist Dr. Sonal Shah to review vascular anomalies. Learn how to diagnose, evaluate, and treat lesions including infantile hemangiomas and capillary malformations.

Most people think dementia starts with memory loss. But for millions, it actually begins decades earlier: in the blood vessels. Long before someone forgets a name or misses an appointment, the brain is being quietly damaged by high blood pressure, cholesterol imbalance, poor sleep, inflammation, and chronic stress, day after day, year after year. This kind of damage doesn't look dramatic. There's no big stroke, no clear warning sign. It happens slowly and silently, which is why it's so often missed until it's too late. But here's the good news: vascular dementia is one of the most preventable and manageable forms of cognitive decline. When caught early, lifestyle changes and medical interventions can help slow the onset and manage the effects. In this episode, we explore: What vascular dementia and vascular cognitive impairment are, and how they differ from Alzheimer's disease Why most dementia cases involve both vascular damage and neurodegenerative pathology (mixed dementia) How blood vessel damage begins in childhood and accumulates silently for decades The role of high blood pressure, cholesterol, diabetes, sleep disorders, and chronic stress in damaging brain vasculature Why slowed thinking, movement, and processing speed are hallmark signs of vascular cognitive decline The critical importance of the endothelium: the thin lining of blood vessels that controls brain health How lifestyle factors like nutrition, exercise, sleep, and stress management protect and repair vascular health Why managing blood pressure early is one of the most powerful interventions for long-term brain health (and why everyone should have a blood pressure monitor at home!) How vascular damage can be slowed, even in midlife Practical steps for prevention across the lifespan, from childhood through older adulthood Our guest for this episode is DR. COLUMBUS BATISTE, a board-certified interventional cardiologist, an incredible science communicator, and author of 'Selfish: A Cardiologist's Guide to Healing a Broken Heart'. Dr. Batiste brings deep expertise on how cardiovascular health shapes brain health, and why protecting the endothelium (the inner lining of blood vessels) is foundational to longevity. His work emphasizes that all roads to longevity are paved by the heart, and what's good for the heart is good for the brain! 'Your Brain On…' is hosted by neurologists, scientists, and public health advocates Drs. Ayesha and Dean Sherzai. SUPPORTED BY: NEURO World, a science-based brain health community designed to help you protect your brain long before problems begin. Learn more at https://neuro.world/  'Your Brain On… Vascular Dementia' • SEASON 6 • EPISODE 8 ——— LINKS Dr. Columbus Batiste: https://drbatiste.com/  Instagram: @HeartHealthyDoc Facebook: https://www.facebook.com/drbatiste  ——— FOLLOW US Join NEURO World: https://neuro.world/   Instagram: https://www.instagram.com/thebraindocs   YouTube: https://www.youtube.com/thebraindocs ——— REFERENCES Core Definitions & Diagnostic Framework • Diagnostic and Statistical Manual of Mental Disorders (5th ed.) - American Psychiatric Publishing • Vascular contributions to cognitive impairment and dementia - https://doi.org/10.1161/STR.0b013e3182299496 • Classifying neurocognitive disorders: The DSM-5 approach - https://doi.org/10.1038/nrneurol.2014.181  Epidemiology & Public Health Burden • Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease - https://doi.org/10.1007/s00401-016-1571-z • Vascular dementia - https://doi.org/10.1016/S0140-6736(15)00463-8  • Risk reduction of cognitive decline and dementia: WHO guidelines - WHO Press Small Vessel Disease & Subcortical Vascular Dementia • Small vessel disease: Mechanisms and clinical implications - https://doi.org/10.1016/S1474-4422(19)30079-1  • Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges - https://doi.org/10.1016/S1474-4422(10)70104-6  • The clinical importance of white matter hyperintensities on brain magnetic resonance imaging - https://doi.org/10.1136/bmj.c3666  Mixed Dementia & Alzheimer–Vascular Overlap • Mixed brain pathologies account for most dementia cases in community-dwelling older persons - https://doi.org/10.1212/01.wnl.0000271090.28148.24 • Early role of vascular dysregulation on late-onset Alzheimer's disease - https://doi.org/10.1016/j.neurobiolaging.2016.04.009 • The pathobiology of vascular dementia - https://doi.org/10.1016/j.neuron.2013.10.008  Cerebral Amyloid Angiopathy (CAA) • Cerebral amyloid angiopathy and Alzheimer disease—one peptide, two pathways - https://doi.org/10.1038/s41582-019-0281-2 • Emerging concepts in sporadic cerebral amyloid angiopathy - https://doi.org/10.1093/brain/awx047 Genetics, Inflammation, and Repair • Apolipoprotein E controls cerebrovascular integrity via cyclophilin A - https://doi.org/10.1038/nature11087 • TREM2—A key player in microglial biology and Alzheimer disease - https://doi.org/10.1038/s41582-018-0072-1  Prevention & Vascular Risk Factors • Dementia prevention, intervention, and care: 2020 report of the Lancet Commission - https://doi.org/10.1016/S0140-6736(20)30367-6  • Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease - https://doi.org/10.1038/s41582-018-0070-3  Further Reading • The role of vascular risk factors in Alzheimer's disease - https://doi.org/10.1038/s41582-021-00530-4

Dr. Tesha Monteith talks with Dr. Michael Eller about the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke.  Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Behind the Knife ABSITE 2026 – Up-to-date and high yield learning to help you DOMINATE the exam. Don't forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheet Be sure to check out our free study aid, which includes all 32 review episodes, brief written summaries, high yield images, and flash cards. Simply create an account on our iOS or Android app or on our website and you will find the entire course in your Library.  Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Google Play App Store: https://play.google.com/store/apps/details?id=com.btk.app Behind the Knife would like to sincerely thank Medtronic for sponsoring the entire 2026 ABSITE podcast series.  Medtronic has a rich history of supporting surgical education, and we couldn't be happier that they chose to partner with Behind the Knife.  Learn more at https://www.medtronic.com/en-us/index.html If you like the work that Behind the Knife is doing, please leave us a review wherever you listen to podcasts.   Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   Check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Behind the Knife in Español - repaso para el examen de certificación en cirugía general: https://app.behindtheknife.org/premium/repaso-para-el-examen-de-certificaci-n-en-cirug-a-general